Peptide Therapy in Dubai: A Complete Guide for UAE Residents

A practical guide to prescription peptide therapy in Dubai and the UAE: which peptides are available, how the consultation pathway works, and why pharmaceutical-grade sourcing matters.

By UAE Peptide Clinic Medical Team

Peptides are short chains of amino acids that act as biological signalling molecules. They are not supplements. In the UAE they are prescription items, dispensed by licensed facilities and prescribed by registered physicians after clinical assessment. This guide explains what peptide therapy involves for UAE residents, which protocols UAE Peptide Clinic works with, and how the pathway from enquiry to delivery actually operates in Dubai.

Why Dubai has become a regional hub

Several factors have converged. Dubai Healthcare City and the wider DHA framework provide a regulated environment for licensed physicians and compounding facilities. Cold-chain logistics across the emirates are mature. And the resident population is unusually health-engaged, with high uptake of preventive screening. The result is that patients can access physician-supervised protocols locally rather than importing unregulated products, which is both safer and legal.

Which peptides are available

The consultation pathway

The process is deliberately clinical. It begins with an online intake covering health history, current medications, prior investigations and goals. A DHA-registered physician then conducts a video review, discusses what the evidence does and does not support, and decides whether a prescription is appropriate. If it is, a protocol is designed with a defined dose, frequency and duration. The prescription is dispensed by a licensed compounding facility and delivered under cold chain.

Pharmaceutical grade versus grey market

A large volume of peptide material circulates online labelled for research use only. That labelling exists precisely because the material has not been manufactured or tested to standards intended for human administration. Purity, sterility, endotoxin load and actual peptide content are unverified. There is no physician oversight, no contraindication screening, and no route to redress if something goes wrong. Prescription supply in the UAE addresses each of those gaps, and that difference is the entire reason a clinical pathway exists.

Who UAE Peptide Clinic is

UAE Peptide Clinic operates as Aevum Health Solutions FZCO, an IFZA-registered company holding licence 90017, working with DHA-registered physicians and licensed compounding partners. The clinic does not sell peptides as consumer products. It arranges physician-supervised access where a clinician has determined a protocol is appropriate, and it declines cases where it is not.

Setting expectations

Peptide research is genuinely active, and for some molecules, such as Tesamorelin and Thymosin Alpha-1, there is substantial human trial data. For others, including BPC-157, preclinical studies suggest plausible mechanisms while human clinical evidence remains limited. No responsible clinic should promise an outcome. Physician assessment determines suitability, protocols are reviewed rather than repeated indefinitely, and individual responses vary. If you are a UAE resident considering peptide therapy, the first step is a consultation, not a purchase.

Browse all peptide protocols available at UAE Peptide Clinic — physician-supervised, pharmaceutical-grade, cold-chain delivered across the UAE. Browse All Protocols